ARGX vs RVMD: stock comparison and AI forecast
Argenx Se (ARGX) and Revolution Medicines, Inc. (RVMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARGX Argenx Se
- Price
- $927.21 +17.8% · 6M
- Market Cap
- $57.38B
- P/E Ratio
- 24.3x
- Size
- large-cap
- AI Forecast
RVMD Revolution Medicines, Inc.
- Price
- $177.65 +24.7% · 6M
- Market Cap
- $38.08B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ARGX is 1.5 times larger than RVMD by market capitalization ($57.38B against $38.08B).
- Over the last six months RVMD returned +24.7% and ARGX +17.8%.
- RVMD carries 0.79 times debt per unit of equity, against 0.19 times for ARGX.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARGX | RVMD |
|---|---|---|
| Market Cap | $57.38B | $38.08B |
| P/E Ratio | 24.32x | – |
| P/B Ratio | – | 15.86x |
| EPS | $38.12 | $-9.15 |
| Book Value/Share | – | $11.20 |
| FCF/Share | $13.34 | $-6.72 |
Profitability & Margins
| Metric | ARGX | RVMD |
|---|---|---|
| ROE | 34.2% | -77.9% |
| ROA | 28.9% | -43.5% |
| ROIC | 16.8% | -44.0% |
| Operating Margin | – | -853.0% |
| Net Margin | – | -946.8% |
| EBT Margin | – | -948.0% |
| Tax Rate | -42.2% | 0.2% |
Financial Health
| Metric | ARGX | RVMD |
|---|---|---|
| Current Ratio | 5.23x | 8.36x |
| Quick Ratio | 4.87x | 8.34x |
| D/E Ratio | 0.19x | 0.79x |
| Financial Leverage | 1.19x | 1.79x |
| Interest Coverage | – | -3116.4x |
| Working Capital | $5.58B | $3.50B |
Cash Flow
| Metric | ARGX | RVMD |
|---|---|---|
| Operating Cash Flow | $840M | -$1.43B |
| Free Cash Flow | $826M | -$1.44B |
| Capital Spending | -$14M | -$9M |
| FCF Growth YoY | 0.0% | – |
Operational Efficiency
| Metric | ARGX | RVMD |
|---|---|---|
| Inventory Turnover | 2.0x | – |
| Days Inventory | 179 days | – |
| Payables Period | 479 days | – |
Income Statement
| Metric | ARGX | RVMD |
|---|---|---|
| Operating Income | $1.23B | -$1.69B |
| Net Income | $2.51B | -$1.87B |
| R&D Expense | $3.43B | $1.45B |
| SG&A Expense | $3.52B | – |
| Cost of Goods Sold | $965M | – |
Dividend & Shareholder Information
| Metric | ARGX | RVMD |
|---|---|---|
| Shares Outstanding | 62M | 214M |
ARGX vs RVMD: stock comparison and AI forecast
Which is bigger, ARGX or RVMD?
ARGX is 1.5 times larger than RVMD by market capitalization ($57.38B against $38.08B).
Which stock performed better over the last six months, ARGX or RVMD?
Over the last six months RVMD returned +24.7% and ARGX +17.8%.
Which one does Intratio's AI model rank higher, ARGX or RVMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.